{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:23:48Z","timestamp":1787027028097,"version":"build-2736575974"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006345","name":"Uniwersytet Mikolaja Kopernika w Toruniu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Psychotropic drugs strongly affect the human psyche through their ability to modulate the neurotransmitter activity and to treat mental disorders and diseases. Monitoring of psychotropic drugs in clinical studies is significant. Thus. establishing methodologies for analyzing these drugs and their pharmacologically active metabolites in biological matrices is essential for patients\u2019 safety. Therefore, therapeutic drug monitoring (TDM) of these drugs in patients receiving pharmacotherapy in psychiatric hospitals is necessary to avoid medical complications, psychiatric adverse effects, or poisoning. In addition to TDM, the main factor in pharmacokinetics that should be monitored along with the drug is its metabolic pathway. The literature on transformation products (TPs) resulting from the psychotropic drug degradation is limited. Hence, to investigate the potential TPs of target compounds, electrochemistry (EC) and liver microsome assays were used to generate TPs, which were further characterized using liquid chromatography-tandem mass spectrometry (LC-MS\/MS). The results obtained by EC-(LC)-MS and liver microsome assays were compared with conventional\n                      <jats:italic>in vivo<\/jats:italic>\n                      studies by analyzing biological samples (human plasma) from patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The electrochemical mimicry of the oxidative phase I and II metabolism was achieved in a thin-layer cell equipped with a boron-doped diamond (BDD) working electrode under controlled potential conditions. Structures were proposed for the electrochemically generated products based on the MS\/MS experiments. Moreover, in order to examine the proposed metabolic pathways of target compounds, the incubation with human liver microsomes was applied. Additionally, a sensitive, specific, and rapid LC-MS\/MS method was developed and validated to quantify selected drugs and their metabolites in biological samples. The preparation of biological samples was accomplished through microextraction by a packed sorbent (MEPS). Finally, the results from LC-MS\/MS analysis of biological samples, liver microsomes and electrochemical TPs were compared to evaluate the quality of electrochemical metabolism mimicry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results and discussion<\/jats:title>\n                    <jats:p>\n                      Data from\n                      <jats:italic>in vivo<\/jats:italic>\n                      experiments agreed with the data from electrochemical oxidation, which predicted some of the potential metabolites found in the human liver microsomes. EC\u2013(LC)-MS is well-suited for the simulation of the oxidative metabolism of selected psychotropic drugs and acts as the orthogonal source of information about drug metabolites compared to liver microsomes and biological matrices. EC-(LC)-MS enables the direct identification of reactive TPs, circumvents time-consuming sample preparation and is ethically advantageous because it reduces the need for animal experiments.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2025.1637852","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T04:10:28Z","timestamp":1756354228000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Electrochemical simulation of psychotropic drug metabolism compared to in vivo processes using liquid chromatography and mass spectrometry"],"prefix":"10.3389","volume":"16","author":[{"given":"Paulina","family":"Jerszy\u0144ska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Szultka-M\u0142y\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1124\/dmd.112.045237","article-title":"Metabolism of the active metabolite of quetiapine, N-desalkylquetiapine in vitro","volume":"40","author":"Bakken","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1016\/j.chroma.2009.02.001","article-title":"Metabolic studies of tetrazepam based on electrochemical simulation in comparison to in vivo and in vitro methods","volume":"1216","author":"Baumann","year":"2009","journal-title":"J. Chrom. A"},{"key":"B3","first-page":"241","article-title":"Citalopram-a review of pharmacological and clinical effects","volume":"25","author":"Bezchlibnyk-Butler","year":"2000","journal-title":"J. Psychiatry Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.trac.2015.02.017","article-title":"Electrochemistry-mass spectrometry to study reactive drug metabolites and CYP450 simulations","volume":"70","author":"Bussy","year":"2015","journal-title":"Trends Anal. Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1002\/rcm.7982","article-title":"Identification and characterization of vilazodone metabolites in rats and microsomes by ultrahigh-performance liquid chromatography\/quadrupole time-of-flight tandem mass spectrometry","volume":"31","author":"Chavan","year":"2017","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"B6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jelechem.2015.10.041","article-title":"Electrochemistry-coupled to mass spectrometry in simulation of metabolic oxidation of methimazole: identification and characterization of metabolites","volume":"761","author":"Chipiso","year":"2016","journal-title":"J. Electroanal. Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1021\/acs.chemrestox.0c00224","article-title":"GLORYx: prediction of the metabolites Resulting from Phase 1 and Phase 2 Biotransformations of Xenobiotics","volume":"15","author":"de Bruyn Kops","year":"2021","journal-title":"Chem. Res. Toxicol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13321-018-0324-5","article-title":"BioTransformer: a comprehensive computational tool for small molecule metabolism prediction and metabolite identification","volume":"11","author":"Djoumbou-Feunang","year":"2019","journal-title":"J. Cheminform"},{"key":"B9","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S0893-133X(98)00113-4","article-title":"O- and N-demethylation of venlafaxine in vitro by human liver microsomes and by microsomes from cDNA-transfected cells: effect of metabolic inhibitors and SSRI antidepressants","volume":"20","author":"Fogelman","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3904\/kjim.2009.24.1.1","article-title":"Overview of therapeutic drug monitoring","volume":"24","author":"Kang","year":"2009","journal-title":"Korean J. Intern Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1002\/anie.200301763","article-title":"Electrochemistry\/Mass spectrometry (EC\/MS)-A new tool to Study drug metabolism and reaction mechanisms","volume":"43","author":"Karst","year":"2004","journal-title":"Angew. Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"358","DOI":"10.2133\/dmpk.22.358","article-title":"Pharmacokinetics of aripiprazole, a new antipsychotic, following oral dosing in healthy adult Japanese volunteers: influence of CYP2D6 polymorphism","volume":"22","author":"Kubo","year":"2007","journal-title":"Drug Metab. Pharmacokinet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.electacta.2015.01.190","article-title":"Electrochemical oxidation of fesoterodine and identification of its oxidation products using liquid chromatography and mass spectrometry","volume":"159","author":"Ku\u010derov\u00e1","year":"2015","journal-title":"Electrochimica Acta"},{"key":"B14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4088\/jcp.v60n0108","article-title":"Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics","volume":"60","author":"Lane","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"B15","first-page":"8","article-title":"Electrochemistry and LC\u2013MS for metabolite generation and identification: tools, technologies and trends","volume":"23","author":"Lohmann","year":"2010","journal-title":"LC GC Eur."},{"key":"B16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00216-011-5679-7","article-title":"Investigation of some biologically relevant redox reactions using electrochemical mass spectrometry interfaced by desorption electrospray ionization","volume":"403","author":"Lu","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.chroma.2015.09.076","article-title":"Identification and quantification of electrochemically generated metabolites of thyroxine by means of liquid chromatography\/electrospray-mass spectrometry and counter gradient liquid chromatography\/inductively coupled plasma-mass spectrometry","volume":"1419","author":"Mak","year":"2015","journal-title":"J. Chromatogr. A"},{"key":"B18","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/BF02244986","article-title":"Plasma protein binding of risperidone and its distribution in blood","volume":"114","author":"Mannens","year":"1994","journal-title":"Psychopharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"7625","DOI":"10.1021\/ac101364s","article-title":"Lidocaine oxidation by electrogenerated reactive oxygen species in the light of oxidative drug metabolism","volume":"82","author":"Nouri-Nigjeh","year":"2010","journal-title":"Anal. Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.aca.2009.10.004","article-title":"A review of current trends and advances in modern bio analytical methods: chromatography and sample preparation","volume":"656","author":"Nov\u00e1kov\u00e1","year":"2009","journal-title":"Anal. Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2174\/138955708783331586","article-title":"Electrochemistry-mass spectrometry in drug metabolism and protein research","volume":"8","author":"Permentier","year":"2008","journal-title":"Mini-Rev. Med. Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.chroma.2012.03.088","article-title":"Identification and quantification of potential metabolites of Gd-based contrast agents by electrochemistry\/separations\/mass spectrometry","volume":"1240","author":"Telgmann","year":"2012","journal-title":"J. Chromatogr. A"},{"key":"B23","doi-asserted-by":"publisher","first-page":"4026","DOI":"10.3390\/molecules25174026","article-title":"Review of chromatographic methods coupled with modern detection techniques applied in the Therapeutic Drugs Monitoring (TDM)","volume":"25","author":"Tuzimski","year":"2020","journal-title":"Molecules"},{"key":"B24","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1007\/s00216-005-3053-3","article-title":"Prediction of clozapine metabolism by on-line electrochemistry\/liquid chromatography\/mass spectrometry","volume":"382","author":"van Leeuwen","year":"2005","journal-title":"Anal. Bioanal. Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1111\/bcp.13242","article-title":"Efficacy of olanzapine for the prophylaxis of chemotherapy-induced nausea and vomiting: a meta-analysis","volume":"83","author":"Yang","year":"2017","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1637852\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T04:10:29Z","timestamp":1756354229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1637852\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":25,"alternative-id":["10.3389\/fphar.2025.1637852"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1637852","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"article-number":"1637852"}}